The counter opened at Rs 352.7 and touched an intraday high and low of Rs 355.2 and Rs 352.7, respectively, in the session so far. Shares of the company of Biocon Ltd. quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 327.75.
Total market cap of the Biocon Ltd. stood at Rs 42495.24 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 1807.8 crore for the quarter ended 30-Jun-2021, down 11.56 per cent from previous quarter’s Rs 2044.1 crore and down 7.0 per cent from the year-ago quarter’s Rs 1689.6 crore.
The net profit for latest quarter stood at Rs 84.4 crore, down 43.51 per cent from the corresponding quarter last year.
Shareholding pattern
As of 30-Jun-2021, DIIs held 2.6 per cent stake in the firm, while foreign institutional investors held 16.52 per cent and the promoters 60.64 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 62.91 and a price-to-book ratio of 6.51. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Biocon Ltd. belongs to the Pharma – Indian industry.
